CLASS II Drug recall · Reported 10 Jul 2024 · FDA Enforcement Report

Allopurinol Tablets, USP 300mg recalled by Dr. Reddy's Laboratories

Dr. Reddy's Laboratories is recalling Allopurinol Tablets, USP 300mg per, distributed in Illinois, Mississippi, Ohio. The recall was initiated on 7 Jun 2024 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesL2300594
NDC55111-729, 55111-730
UPC0355111729013, 0355111730019
Quantity recalled20,520 units

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0583-2024
FDA event ID
94781
Recalling firm
Dr. Reddy's Laboratories, Princeton, NJ
Manufacturer
Dr. Reddy's Laboratories Limited
Classification
Class II
Status
Terminated
Recall initiated
7 Jun 2024
FDA classified
3 Jul 2024
Reported
10 Jul 2024
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

7 Jun 2024Recall initiated by company
3 Jul 2024Classified by FDA+26 days
10 Jul 2024Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Presence of foreign substance.

Product as listed by the FDA

Allopurinol Tablets, USP 300mg, 100 Tablets per bottle, Rx only, Manufactured By: Dr. Reddy's Laboratories LA LLC, Shreveport, LA 71106 USA, NDC 55111-730-01.

Where it was distributed

IL, MS, OH

IllinoisMississippiOhio

Questions about this recall

Why was it recalled?

Presence of foreign substance.

Which lots are affected?

L2300594

Where was it sold?

IL, MS, OH

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Dr. Reddy's Laboratories

All 165

Other Allopurinol recalls

All 7